Fellaz Launches Decentralized Entertainment Protocol Stack | Massive Giveaway Live: Win $3,000 Beta Access + Over 2,000 USDT
SINGAPORE, July 4, 2025 /PRNewswire/ -- Web3 entertainment protocol Fellaz has officially…
Shah Rukh Khan to Grace the Grand Opening of City of Dreams Sri Lanka
MUMBAI, India, July 4, 2025 /PRNewswire/ -- The undisputed King of Bollywood, Shah…
Good Game, World’s First As-live Global Gaming Reality Show announced
NEW YORK, July 2, 2025 /PRNewswire/ -- Good Game Group Inc. has announced the…
HH Global assembles leadership team to establish Nuevo as global creative ecosystem
LONDON, July 2, 2025 /PRNewswire/ -- HH Global, the world's leading responsible…
Bybit TradFi x Crypto Report: Regulatory Tailwinds Drive Coinbase Outperformance Despite Premium Valuation
DUBAI, UAE, July 4, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency…
Vantage Shines at Money Expo Colombia 2025 with Industry Recognition and Dynamic Engagement
PORT VILA, Vanuatu, July 4, 2025 /PRNewswire/ -- Vantage Markets wrapped up…
ASYAD GROUP SUCCESSFULLY COMPLETES COMPLEX AIR CARGO OPERATION TO MAJOR ASIAN ECONOMIC HUB
MUSCAT, Oman, July 3, 2025 /PRNewswire/ -- Asyad Group, Oman's global integrated…
Wynn Macau and Wynn Palace Will Host Asia’s 50 Best Bars 2025 Awards This July
Wynn announces its curated events program for Asia's 50 Best Bars 2025,…
Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessas Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist
July 04, 2025 03:00 ET | Source: Nxera Pharma Tokyo, Japan and…
AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer
PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3…